Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 301–400 of 1,065
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice
Wang, P., Li, D., Ke, W., Liang, D., Hu, X., & Chen, F. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0332-1 · Cited by 301
Intestinal microbiota in inflammatory bowel disease: Friend of foe?
Fava, F. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.557 · Cited by 300
Remely, M., Aumueller, E., Merold, C., Dworzak, S., Hippe, B., Zanner, J., Pointner, A., Brath, H., & Haslberger, A. G. (2014) · Gene · doi:10.1016/j.gene.2013.11.081 · Cited by 299
“The number of Bacteroides depends on the weight loss whereas the Firmicutes group remained unchanged and no correlation with total caloric intake was detectable (Cani et al., 2008).”
BackgroundTan, Y., Chang, S. K. C., & Zhang, Y. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2016.06.100 · Cited by 299
Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease
Kikuchi, K., Saigusa, D., Kanemitsu, Y., Matsumoto, Y., Thanai, P., Suzuki, N., Mise, K., Yamaguchi, H., Nakamura, T., Asaji, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09735-4 · Cited by 298
Gaudino, S. J., & Kumar, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00360 · Cited by 298
Green, M., Arora, K., & Prakash, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082890 · Cited by 293
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00472-y · Cited by 294
Parnell, J. A., & Reimer, R. A. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511003163 · Cited by 294
“Furthermore, the gut microbiota has also been shown to play a role in metabolic endotoxaemia, the low-grade inflammatory tone linked to obesity and many of its co-morbidities((21,22)).”
BackgroundThe prenatal gut microbiome: are we colonized with bacteria in utero ?
Walker, R. W., Clemente, J. C., Peter, I., & Loos, R. J. F. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12217 · Cited by 293
“Western diets are known to alter the gut microbiome (101,102) and are associated with increased intestinal permeability in human and animal studies (103,104).”
Role of melatonin in sleep deprivation‐induced intestinal barrier dysfunction in mice
Gao, T., Wang, Z., Dong, Y., Cao, J., Lin, R., Wang, X., Yu, Z., & Chen, Y. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12574 · Cited by 292
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice
Ritze, Y., Bárdos, G., Claus, A., Ehrmann, V., Bergheim, I., Schwiertz, A., & Bischoff, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0080169 · Cited by 292
“In recent years, it became evident, that low grade inflammation due to metabolic endotoxemia has an implication on various diseases [19].”
BackgroundEverard, A., Matamoros, S., Geurts, L., Delzenne, N. M., & Cani, P. D. (2014) · mBio · doi:10.1128/mbio.01011-14 · Cited by 292
Self-citationThe Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
An, L., Wirth, U., Koch, D., Schirren, M., Drefs, M., Koliogiannis, D., Nieß, H., Andrassy, J., Guba, M., Bazhin, A. V., et al. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05188-7 · Cited by 284
Inflammatory lipid mediators in adipocyte function and obesity
Iyer, A., Fairlie, D. P., Prins, J. B., Hammock, B. D., & Brown, L. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.264 · Cited by 285
Innate immunity and adipose tissue biology
Schäffler, A., & Schölmerich, J. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.03.001 · Cited by 283
Gut Microbiota Composition and Blood Pressure: The CARDIA Study
Sun, S., Lulla, A., Sioda, M., Winglee, K., Wu, M. C., Jacobs, D. R., Shikany, J. M., Lloyd-Jones, D. M., Launer, L. J., Fodor, A. A., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12109 · Cited by 282
Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
“important contribution to these mechanisms [11–16].”
RetractedFlavonoids and the gastrointestinal tract: local and systemic effects
Oteiza, P. I., Fraga, C. G., Mills, D. A., & Taft, D. H. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.001 · Cited by 281
Melatonin prevents obesity through modulation of gut microbiota in mice
Xu, P., Wang, J., Hong, F., Wang, S., Jin, X., Xue, T., Jia, L., & Zhai, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12399 · Cited by 281
Grasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J. E., Tercé, F., & Burcelin, R. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.013 · Cited by 281
“In conclusion, we show here that in HFD-fed mice with T2D, a specific set of ileum bacteria hampers GLP-1r in the ENS which reduces GLP-1-induced NO production through a NOD2/TLR4/ CD14-dependant mechanism, hence preventing the activation of the gut-brain-periphery axis for the control of insulin secretion and gastric…”
BackgroundInfluentialSelf-citationGeurts, L., Neyrinck, A. M., Delzenne, N. M., Knauf, C., & Cani, P. D. (2014) · Beneficial Microbes · doi:10.3920/bm2012.0065 · Cited by 277
“Because gut microbiota contribute to low-grade inflammation associated with obesity by increasing gut permeability and metabolic endotoxaemia (Cani et al., 2007a, 2008, 2009b), we hypothesised that the eCB system could link the gut microbiota to peripheral inflammation and metabolism (Muccioli et…”
BackgroundSelf-citationEvaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277
CNS leptin and insulin action in the control of energy homeostasis
Belgardt, B. F., & Brüning, J. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05799.x · Cited by 276
Sun, L., Yu, Z., Ye, X., Zou, S., Li, H., Yu, D., Wu, H., Chen, Y., Dore, J., Clément, K., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0340 · Cited by 278
“The occurrences of metabolic response could be counteracted by CD14 mutant (5) or improved by changing gut microbiota (4).”
BackgroundInfluentialStrissel, K. J., DeFuria, J., Shaul, M. E., Bennett, G., Greenberg, A. S., & Obin, M. S. (2010) · Obesity · doi:10.1038/oby.2010.1 · Cited by 275
“Other factors that could promote Th1 responses in eAT include HFD-associated systemic endotoxemia (34) as well as endogenous signals released from dying adipocytes and surrounding matrix (damage-associated molecular patterns (DAMPS)) that can act as immune adjuvants and favor Th1 polarization (reviewed in (35)).”
BackgroundBlood-brain barrier permeability and physical exercise
Małkiewicz, M. A., Szarmach, A., Sabisz, A., Cubała, W. J., Szurowska, E., & Winklewski, P. J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1403-x · Cited by 276
Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?
Harris, K., Kassis, A., Major, G., & Chou, C. J. (2012) · Journal of Obesity · doi:10.1155/2012/879151 · Cited by 276
“Finally, it was found that ob/ob mice or high-fat-diet-fed C57BL/6J mice treated with ampicillin and neomycin had altered gut microbiota composition and reduced endotoxemia with improved glucose tolerance [61].”
BackgroundCircadian rhythm and the gut microbiome
Voigt, R. M., Forsyth, C. B., Green, S. J., Engen, P. A., & Keshavarzian, A. (2016) · International Review of Neurobiology · doi:10.1016/bs.irn.2016.07.002 · Cited by 274
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
The Role of Gut Microbiota on Insulin Resistance
Caricilli, A., & Saad, M. (2013) · Nutrients · doi:10.3390/nu5030829 · Cited by 274
“antibiotics reduced normal plasma LPS values, reducing the occurrence of adipose tissue inflammation, oxidative stress and macrophage markers, as well as preventing adipocyte hypertrophy and improving metabolic parameters of diabetes and obesity in high-fat diet-fed mice [11].”
BackgroundThe Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
“Since it has been reported that serum endotoxin levels are elevated in obese animals due to a disruption in intestinal integrity (Cani et al., 2008), LPS may serve as a first signal in obese individuals.”
BackgroundKang, C., Wang, B., Kaliannan, K., Wang, X., Lang, H., Hui, S., Huang, L., Zhang, Y., Zhou, M., Chen, M., et al. (2017) · mBio · doi:10.1128/mbio.00470-17 · Cited by 272
“…P (cid:4) 0.05) by one-way ANOVA with a post hoc Bonferroni’s multiple-comparison test. microbiota leads to metabolic endotoxemia (passage of LPS to systemic circulation) through leaky gut (5), so we next measured the plasma LPS levels by Limulus amebo-cyte lysate (LAL) chromogenic endpoint assay.”
InfluentialMurphy, E. F., Cotter, P. D., Hogan, A., O'Sullivan, O., Joyce, A., Fouhy, F., Clarke, S. F., Marques, T. M., O'Toole, P. W., Stanton, C., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-300705 · Cited by 272
van den Munckhof, I. C. L., Kurilshikov, A., ter Horst, R., Riksen, N. P., Joosten, L. A. B., Zhernakova, A., Fu, J., Keating, S. T., Netea, M. G., de Graaf, J., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12750 · Cited by 270
“High fat diet (HFD)-fed mice treated with antibiotics showed an increase in Prevotella species and a decrease in endotoxemia (63).”
BackgroundIsmail, N. A., Ragab, S. H., ElBaky, A. A., Shoeib, A. R. S., Alhosary, Y., & Fekry, D. (2011) · Archives of Medical Science · doi:10.5114/aoms.2011.23418 · Cited by 271
“Recently, metabolic endotoxaemia, characterized by an increase in serum LPS levels, has been demon strated to be an inflammatory factor, causing body weight gain, insulin resistance, and diabetes in high-fat fed animal models [17-19].”
BackgroundChuang, C.-C., & McIntosh, M. K. (2011) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145149 · Cited by 270
The effect of diet and exercise on intestinal integrity and microbial diversity in mice
Campbell, S. C., Wisniewski, P. J., Noji, M., McGuinness, L. R., Häggblom, M. M., Lightfoot, S. A., Joseph, L. B., & Kerkhof, L. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150502 · Cited by 268
“Dysbiois promotes the release of endotoxin and flagellin from gram negative bacteria, which bind to TLR5, inducing inflammation and damage of the intestinal epithelium [12,19].”
BackgroundSuriano, F., Vieira-Silva, S., Falony, G., Roumain, M., Paquot, A., Pelicaen, R., Régnier, M., Delzenne, N. M., Raes, J., Muccioli, G. G., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01097-8 · Cited by 263
Self-citationGut microbiota influence in type 2 diabetes mellitus (T2DM)
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00446-0 · Cited by 270
Kang, Y., Kang, X., Yang, H., Liu, H., Yang, X., Liu, Q., Tian, H., Xue, Y., Ren, P., Kuang, X., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2021.106020 · Cited by 264
Dewulf, E. M., Cani, P. D., Neyrinck, A. M., Possemiers, S., Holle, A. V., Muccioli, G. G., Deldicque, L., Bindels, L. B., Pachikian, B. D., Sohet, F. M., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.05.009 · Cited by 269
“Additionally, changes in gut microbiota composition were shown in different mice models of obesity, including ob/ob mice, and obese mice fed an HF-rich diet [7–10].”
BackgroundSelf-citationPathways in Microbe-Induced Obesity
Cox, L. M., & Blaser, M. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.004 · Cited by 266
“High-fat diet (HFD) can increase absorption of lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls, either by incorporation into chylomicrons or by increasing intestinal permeability (Cani et al., 2007, 2008).”
Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
Fuke, N., Nagata, N., Suganuma, H., & Ota, T. (2019) · Nutrients · doi:10.3390/nu11102277 · Cited by 268
“Oral administration of ampicillin and neomycin, broad-spectrum antibiotics that are poorly absorbed, also suppressed the increase in blood LPS concentration induced by a high-fat diet [10].”
BackgroundInfluentialUnhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases
Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266
“This antibiotic-induced normalization in gut microbiota corresponded to an increase in gut ZO-1 and occludin expression, thus, reversing the intestinal permeability associated with the high-fat diet (Cani et al., 2008).”
Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice
Bagarolli, R. A., Tobar, N., Oliveira, A. G., Araújo, T. G., Carvalho, B. M., Rocha, G. Z., Vecina, J. F., Calisto, K., Guadagnini, D., Prada, P. O., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.08.006 · Cited by 266
Visceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 265
“Moreover, it is conceivable that obesity-associated changes in the composition of the gut microbiota and the resulting release of gut-derived pro-inflammatory and bacterial factors such as endotoxin may contribute to the ‘portal theory’ as large parts of the small bowel are also drained into the portal vein (106).”
BackgroundMetabolic activities and probiotic potential of bifidobacteria
Russell, D. A., Ross, R. P., Fitzgerald, G. F., & Stanton, C. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.06.003 · Cited by 267
Nutrition, inflammation and liver-spleen axis
Barrea, L., Di Somma, C., Muscogiuri, G., Tarantino, G., Tenore, G. C., Orio, F., Colao, A., & Savastano, S. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1353479 · Cited by 263
“Moreover, gastrointestinal tract might represent a potential source of inflammation associated with excess calorie intake (Cani et al. 2007; Cani et al. 2008).”
BackgroundMicrobial impact on cholesterol and bile acid metabolism: current status and future prospects
Kriaa, A., Bourgin, M., Potiron, A., Mkaouar, H., Jablaoui, A., Gérard, P., Maguin, E., & Rhimi, M. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r088989 · Cited by 264
The gut microbiome: the role of a virtual organ in the endocrinology of the host
Evans, J. M., Morris, L. S., & Marchesi, J. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0131 · Cited by 264
“…by Bioscientifica Ltd. Downloaded from Bioscientifica.com at 04/25/2022 06:44:17PM via free access Jo u rn a l o f E n d o cr in o lo g y a high-fat diet leads to the onset of insulin resistance and, therefore, the development of type 2 diabetes in a mouse model (Cani et al. 2007, 2008).”
BackgroundArmah, K. A., McGinnis, K., Baker, J., Gibert, C., Butt, A. A., Bryant, K. J., Goetz, M., Tracy, R., Oursler, K. K., Rimland, D., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis406 · Cited by 262
“Because comorbidities like CVD risk factors are associated with elevated biomarkers of inflammation [25–27], altered coagulation [28–30], and/or monocyte activation [31, 32], the effects of HIV on these biomarkers in HIV-infected veterans may have partially been balanced by the effects of these comorbidities among uni…”
Does lipopolysaccharide-mediated inflammation have a role in OA?
Huang, Z., & Kraus, V. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.158 · Cited by 262
Zhang, X.-Y., Chen, J., Yi, K., Peng, L., Xie, J., Gou, X., Peng, T., & Tang, L. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1842990 · Cited by 260
“Endotoxemia is an important clinical indicator of MDs like obesity.(24) It is characterized by an elevated level of plasma LPS, often resulted from HFD-induced microbial gut dysbiosis.”
BackgroundIntestinal alkaline phosphatase prevents metabolic syndrome in mice
Kaliannan, K., Hamarneh, S. R., Economopoulos, K. P., Nasrin Alam, S., Moaven, O., Patel, P., Malo, N. S., Ray, M., Abtahi, S. M., Muhammad, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220180110 · Cited by 262
“Systemic and local inflammation lead to overexpression of proinflammatory cytokines (12), which cause increased gut permeability (13) and an acceleration of endotoxin translocation (14), resulting in a vicious cycle of endotoxemia.”
Role of the Gut Microbiome in Obesity and Diabetes Mellitus
Barlow, G. M., Yu, A., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 262
Toll-like Receptors in the Vascular System: Sensing the Dangers Within
Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 263
Huang, Z. Y., Stabler, T., Pei, F. X., & Kraus, V. B. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.05.008 · Cited by 262
Araújo, J. R., Tomas, J., Brenner, C., & Sansonetti, P. J. (2017) · Biochimie · doi:10.1016/j.biochi.2017.05.019 · Cited by 261
Bian, X., Chi, L., Gao, B., Tu, P., Ru, H., & Lu, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178426 · Cited by 262
Lecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262
“Bifidobacterium levels were significantly reduced in high-fat-fed mice v. animals that received the standard high-carbohydrate diet (11) .”
Gut microorganisms as promising targets for the management of type 2 diabetes
Delzenne, N. M., Cani, P. D., Everard, A., Neyrinck, A. M., & Bindels, L. B. (2015) · Diabetologia · doi:10.1007/s00125-015-3712-7 · Cited by 262
“altered composition of the gut microbiota and with increased intestinal permeability [15–17].”
BackgroundSelf-citationMira-Pascual, L., Cabrera-Rubio, R., Ocon, S., Costales, P., Parra, A., Suarez, A., Moris, F., Rodrigo, L., Mira, A., & Collado, M. C. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0963-x · Cited by 262
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
“These data indicate that gut microbiota may cause obesity-associated metabolic disorders, to some extent, through LPS-dependent inflammatory mechanisms (Cani et al., 2008) (Fig.”
BackgroundAshrafian, F., Shahriary, A., Behrouzi, A., Moradi, H. R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., Khatami, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02155 · Cited by 254
Ahmadi, S., Wang, S., Nagpal, R., Wang, B., Jain, S., Razazan, A., Mishra, S. P., Zhu, X., Wang, Z., Kavanagh, K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132055 · Cited by 260
Denou, E., Marcinko, K., Surette, M. G., Steinberg, G. R., & Schertzer, J. D. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00537.2015 · Cited by 260
“All of these pathways have been implicated in aspects of 419 host metabolic disease (4, 10, 17, 21, 51, 56).”
BackgroundAnti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Pollack, R. M., Donath, M. Y., LeRoith, D., & Leibowitz, G. (2016) · Diabetes Care · doi:10.2337/dcs15-3015 · Cited by 262
Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders
Singh, R., Zogg, H., Wei, L., Bartlett, A., Ghoshal, U. C., Rajender, S., & Ro, S. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20149 · Cited by 259
“Mainly, intestinal barrier dysfunction caused by microbial dysbiosis plays a critical component in the development of immune dysregulation leading to GI and metabolic disease.(123) Recently, in a study published in Science by Thaiss et al,(124) T2D and obesity mouse models showed that hyperglycemia led to intestinal b…”
BackgroundGut Microbiota and Metabolic Disorders
Hur, K. Y., & Lee, M.-S. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.3.198 · Cited by 259
“2) [21-23].”
Shang, Q., Song, G., Zhang, M., Shi, J., Xu, C., Hao, J., Li, G., & Yu, G. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.11.002 · Cited by 258
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 257
Self-citationProgramming of Host Metabolism by the Gut Microbiota
Bäckhed, F. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000328042 · Cited by 255
“Interestingly, treatment of obese mice with antibiotics reduces plasma endotoxin levels, adipose inflammation, adiposity and liver triglycerides, and improves host glucose metabolism [”
BackgroundGut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash, S., Rodes, L., Coussa-Charley, M., Tomaro-Duchesneau, C., Tomaro-Duchesneau, C., Coussa-Charley, & Rodes (2011) · Biologics: Targets and Therapy · doi:10.2147/btt.s19099 · Cited by 256
Lelouvier, B., Servant, F., Païssé, S., Brunet, A., Benyahya, S., Serino, M., Valle, C., Ortiz, M. R., Puig, J., Courtney, M., et al. (2016) · Hepatology · doi:10.1002/hep.28829 · Cited by 242
“Importantly, in metabolic diseases such as obesity and type 2 diabetes, gut microbiota dysbiosis increases intestinal permeability((16,17)) and bacterial translocation.”
BackgroundSelf-citationKaliannan, K., Robertson, R. C., Murphy, K., Stanton, C., Kang, C., Wang, B., Hao, L., Bhan, A. K., & Kang, J. X. (2018) · Microbiome · doi:10.1186/s40168-018-0587-0 · Cited by 253
NOD1 activators link innate immunity to insulin resistance
Schertzer, J. D., Tamrakar, A. K., Magalhães, J. G., Pereira, S., Bilan, P. J., Fullerton, M. D., Liu, Z., Steinberg, G. R., Giacca, A., Philpott, D. J., et al. (2011) · Diabetes · doi:10.2337/db11-0004 · Cited by 253
“Given the known immunoactive nature of PGN and the fact that antibiotic treatment can attenuate HFD-induced insulin resistance (13), these results position PGN as a potential link between innate immunity and insulin resistance.”
BackgroundResultCaesar, R., Fåk, F., & Bäckhed, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02270.x · Cited by 253
Tomas, J., Mulet, C., Saffarian, A., Cavin, J.-B., Ducroc, R., Regnault, B., Kun Tan, C., Duszka, K., Burcelin, R., Wahli, W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612559113 · Cited by 249
“Furthermore, insulin resistance, which is associated with obesity, is considered the result of chronic low-grade inflammation of the tissues caused by transepithelial translocation of enteric bacteria or bacterial products through a failing epithelial barrier (38, 39).”
BackgroundMethodSelf-citationEffects of obesity on depression: A role for inflammation and the gut microbiota
Schachter, J., Martel, J., Lin, C.-S., Chang, C.-J., Wu, T.-R., Lu, C.-C., Ko, Y.-F., Lai, H.-C., Ojcius, D. M., & Young, J. D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.026 · Cited by 253
“This elevated intestinal permeability observed in animal models of diet-induced obesity has been called ‘‘leaky gut” (Cani et al., 2008).”
BackgroundMetabolic retroconversion of trimethylamine N-oxide and the gut microbiota
Hoyles, L., Jiménez-Pranteda, M. L., Chilloux, J., Brial, F., Myridakis, A., Aranias, T., Magnan, C., Gibson, G. R., Sanderson, J. D., Nicholson, J. K., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0461-0 · Cited by 252
Lasker, S., Rahman, M. M., Parvez, F., Zamila, M., Miah, P., Nahar, K., Kabir, F., Sharmin, S. B., Subhan, N., Ahsan, G. U., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56538-0 · Cited by 252
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Svegliati-Baroni, G., Pierantonelli, I., Torquato, P., Marinelli, R., Ferreri, C., Chatgilialoglu, C., Bartolini, D., & Galli, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.029 · Cited by 249
Kim, J. J., & Sears, D. D. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/212563 · Cited by 248
“Genetically obese ob/ob mice treated with an LPS inhibitor or in a CD14 KO background have reduced inflammation and metabolic abnormalities compared to normal ob/ob mice [51, 52] which suggests that these ob/ob phenotypes are partly mediated by gut LPS and TLR4 signaling.”
BackgroundInflammageing and metaflammation: The yin and yang of type 2 diabetes
Prattichizzo, F., De Nigris, V., Spiga, R., Mancuso, E., La Sala, L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 249
“Furthermore, genetic ablation of the TLR-4 co-receptor CD14 partially reverses this phenotype (Cani et al., 2008).”
Gut microbiota and non-alcoholic fatty liver disease: new insights
Aron-Wisnewsky, J., Gaborit, B., Dutour, A., & Clement, K. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12140 · Cited by 248
“The role of the gut microbiota was further demonstrated by antibiotic treatment reducing the intensity of the disease in high-fat diet and ob/ob mice [93–95].”
BackgroundConterno, L., Fava, F., Viola, R., & Tuohy, K. M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0230-1 · Cited by 247
“…modified microbiota contributes to increased gut wall permeability and metabolic endotoxemia, which can be reversed by antibiotics Cani et al. (2008) Human pregnant Comparison of the fecal microbiota (flow cytometry FISH, and qPCR) of overweight (n = 18) and normo-weight (n = 36)…”
BackgroundDysbiotic Events in Gut Microbiota: Impact on Human Health
Schippa, S., & Conte, M. (2014) · Nutrients · doi:10.3390/nu6125786 · Cited by 246
“Intestinal dysbiosis has been linked with important human diseases, including autoimmune and/or autoinflammatory disorders, such as IBD, metabolic disorders, such as, obesity, type 2 diabetes [4,5], allergies [6], and neurological disorders [3,7].”
BackgroundThe circadian clock and liver function in health and disease
Mukherji, A., Bailey, S. M., Staels, B., & Baumert, T. F. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.020 · Cited by 246
“A mechanism through which changes in gut microbiota composition may promote NAFLD is through increased LPS production and delivery to the liver via the portal circulation ((98-99)).”
BackgroundGut microbiota, host health, and polysaccharides
Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245
“Consequently, abnormal intestinal microbiota result in an increased endotoxemia which over-produce proinflammatory cytokines promoting metabolic syndrome (Cani et al., 2008).”
Neyrinck, A. M., Possemiers, S., Verstraete, W., De Backer, F., Cani, P. D., & Delzenne, N. M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.008 · Cited by 244
Self-citationRole of resistant starch in improving gut health, adiposity, and insulin resistance
Keenan, M. J., Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon, D. B., & Martin, R. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.007419 · Cited by 243
Zhu, L., Zhang, D., Zhu, H., Zhu, J., Weng, S., Dong, L., Liu, T., Hu, Y., & Shen, X. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.023 · Cited by 243
Prevotella copri increases fat accumulation in pigs fed with formula diets
Chen, C., Fang, S., Wei, H., He, M., Fu, H., Xiong, X., Zhou, Y., Wu, J., Gao, J., Yang, H., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01110-0 · Cited by 242
“Previous reports in mice have also indicated the role of gut bacterial LPS in obesity [45, 46].”
BackgroundPotential mechanisms for the emerging link between obesity and increased intestinal permeability
Teixeira, T. F. S., Collado, M. C., Ferreira, C. L. L. F., Bressan, J., & Peluzio, M. D. C. G. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.07.003 · Cited by 242
Liang, Y., Zhan, J., Liu, D., Luo, M., Han, J., Liu, X., Liu, C., Cheng, Z., Zhou, Z., & Wang, P. (2019) · Microbiome · doi:10.1186/s40168-019-0635-4 · Cited by 240
Zhang, W., Xu, J.-H., Yu, T., & Chen, Q.-K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109131 · Cited by 242
RetractedNon-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
“HFD mice and genetically obese leptin deficient mice develop metabolic endotoxemia [88], indicated by an increase in LPS that was associated with insulin resistance and increased fat deposition.”
BackgroundMethodAndré, C., Dinel, A.-L., Ferreira, G., Layé, S., & Castanon, N. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.012 · Cited by 241
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.